These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20527538)

  • 21. Thermoluminescent and Monte Carlo dosimetry of a new 170Tm brachytherapy source.
    Nazari S; Sadeghi M; Shirvani-Arani S; Bahrami-Samani A; Saidi P
    Phys Med; 2014 Mar; 30(2):178-83. PubMed ID: 23764298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
    Selvam TP; Sahoo S; Vishwakarma RS
    Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Empirical dosimetric characterization of model I125-SL 125iodine brachytherapy source in phantom.
    Wallace RE
    Med Phys; 2000 Dec; 27(12):2796-802. PubMed ID: 11190963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosimetric characteristics of the DRAXIMAGE model LS-1 1-125 interstitial brachytherapy source design: a Monte Carlo investigation.
    Williamson JF
    Med Phys; 2002 Apr; 29(4):509-21. PubMed ID: 11991122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thermoluminescent dosimetry of the SourceTech Medical model STM1251 125I seed.
    Chiu-Tsao ST; Duckworth TL; Hsiung CY; Li Z; Williamson J; Patel NS; Harrison LB
    Med Phys; 2003 Jul; 30(7):1732-5. PubMed ID: 12906190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental determination of the TG-43 dosimetric characteristics of EchoSeed model 6733 I25I brachytherapy source.
    Meigooni AS; Dini SA; Sowards K; Hayes JL; Al-Otoom A
    Med Phys; 2002 Jun; 29(6):939-42. PubMed ID: 12094988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monte Carlo-aided dosimetry of the Symmetra model I25.S06 125I, interstitial brachytherapy seed.
    Hedtjärn H; Carlsson GA; Williamson JF
    Med Phys; 2000 May; 27(5):1076-85. PubMed ID: 10841412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGE 125I brachytherapy source.
    Meigooni AS; Hayes JL; Zhang H; Sowards K
    Med Phys; 2002 Sep; 29(9):2152-8. PubMed ID: 12349937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosimetry for 131Cs and 125I seeds in solid water phantom using radiochromic EBT film.
    Chiu-Tsao ST; Napoli JJ; Davis SD; Hanley J; Rivard MJ
    Appl Radiat Isot; 2014 Sep; 92():102-14. PubMed ID: 25038559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric characteristics of the bests double-wall 103Pd brachytherapy source.
    Meigooni AS; Bharucha Z; Yoe-Sein M; Sowards K
    Med Phys; 2001 Dec; 28(12):2568-75. PubMed ID: 11797962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosimetric characteristic of a new 125I brachytherapy source.
    Sadeghi M; Khanmohammadi Z
    Radiat Prot Dosimetry; 2011 Nov; 147(3):451-6. PubMed ID: 21233096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the physical, spectral, and dosimetric characteristics of a new 125I brachytherapy source.
    Pirchio R; Galiano E; Saraví M; Banchik D; Muñoz C
    Med Phys; 2007 Jul; 34(7):2801-6. PubMed ID: 17821987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental determination of dosimetric characteristics of Best 125I brachytherapy source.
    Meigooni AS; Gearheart DM; Sowards K
    Med Phys; 2000 Sep; 27(9):2168-73. PubMed ID: 11011747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monte Carlo calculation of dosimetry parameters for the IR08-103Pd brachytherapy source.
    Saidi P; Sadeghi M; Shirazi A; Tenreiro C
    Med Phys; 2010 Jun; 37(6):2509-15. PubMed ID: 20632562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of the IsoAid ADVANTAGE (125)I brachytherapy source dosimetric parameters using Monte Carlo simulation.
    Sadeghi M; Hamed Hosseini S
    Appl Radiat Isot; 2010 Jan; 68(1):211-3. PubMed ID: 19762248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric characterization of the GammaClip™ 169Yb low dose rate permanent implant brachytherapy source for the treatment of nonsmall cell lung cancer postwedge resection.
    Currier B; Munro JJ; Medich DC
    Med Phys; 2013 Aug; 40(8):080701. PubMed ID: 23927294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosimetric study of the new Intersource125 iodine seed.
    Reniers B; Vynckier S; Scalliet P
    Med Phys; 2001 Nov; 28(11):2285-8. PubMed ID: 11764034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of encapsulated 170Tm sources for their potential use in brachytherapy.
    Ballester F; Granero D; Perez-Calatayud J; Venselaar JL; Rivard MJ
    Med Phys; 2010 Apr; 37(4):1629-37. PubMed ID: 20443484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calculated dosimetric parameters of the IoGold 125I source model 3631-A.
    Wierzbicki JG; Rivard MJ; Waid DS; Arterbery VE
    Med Phys; 1998 Nov; 25(11):2197-9. PubMed ID: 9829245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A revised dosimetric characterization of the model S700 electronic brachytherapy source containing an anode-centering plastic insert and other components not included in the 2006 model.
    Hiatt JR; Davis SD; Rivard MJ
    Med Phys; 2015 Jun; 42(6):2764-76. PubMed ID: 26127029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.